Followers | 371 |
Posts | 20765 |
Boards Moderated | 4 |
Alias Born | 04/08/2011 |
Wednesday, September 28, 2016 3:36:41 PM
ONCOLOGIX TECH, INC. AND SUBSIDIARIES
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
For the Three Months Ended For the Nine Months Ended
May 31, May 31, May 31, May 31,
2015 2014 2015 2014
Revenues $ 1,235,656 $ 988,385 $ 3,625,407 $ 2,696,776
With subsidiaries STILL in full operation per phone calls today, I'd expect that their revenues have sustained growth despite the legal woes of the parent company that forced it dark since....
What you think?
Damn it feels good to be a gangster.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM